• Dry Cracked Skin
  • Impetigo
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Surgery
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Inflamed Skin

Highlighting the Molluscum Contagiosum Pipeline


In this video, Peter Lio, MD, FAAD, expands on his presentation at the 19th annual Winter Clinical Dermatology Conference by diving into molluscum contagiousum treatment and the potential of cantharidin 0.7% (VP-102; Verrica).

Peter Lio, MD, FAAD, clinical assistant professor of dermatology and pediatrics at Northwestern University Feinberg School of Medicine in Chicago, Illinois; founding director of the Chicago Integrative Eczema Center; and founding partner of Medical Dermatology Associates of Chicago, gave a presentation called, "What's Hot and New in Pediatric Dermatology," at the 19th annual Winter Clinical Dermatology Conference. In this video he goes into deep detail on current treatment, cantharidin 0.7% (VP-102; Verrica) potential FDA approval, and more.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.